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Cancer risk: 
Role of environment
THE REPORT “VARIATION in cancer 
risk among tissues can be explained by 
the number of stem cell divisions” (C. 
Tomasetti and B. Vogelstein, 2 January, 
p. 78) is dangerously misleading because 
it understates the role of prevention in 
cancer causation. It is widely acknowl-
edged that many cancers can be explained 
by a two-step process: initiation by one 
or a series of mutations, followed by the 
promotion of the genetic “mistake” to a 
recognizable tumor or blood disease (1). The 
observation that replication of the mistake 
may proceed at different rates in different 
tissues is no doubt correct. However, some 
mutations are initiated by chemical or 
viral exposures, and others occur without a 
known cause. 
Promotion of DNA damage to recog-
nizable disease occurs in both cases. The 
conclusion that “stochastic effects of DNA 
replication can be…distinguished from 
external environmental factors” is an 
inaccurate statement that rests on a false 
dichotomy. An environmental influence can 
in fact create a DNA change which, if pres-
ent when the DNA is copied, is subsequently 
“fixed” into the genome as a permanent 
change. The more replications, the less time 
there is for DNA repair to take place before 
the next copying/fixation event. Thus, the 
correlation between frequency of copying 
events and lifetime cancer risks among 
tissues does not imply that environmental 
influences play a lesser role in the causa-
tion of those same mutations. The fact 
that age-adjusted cancer rates for different 
tissues vary substantially among countries 
where statistics are kept, and between 
workplaces or communities that differ in 
environmental exposures, demonstrates that 
a large fraction of cancers are influenced by 
environmental factors (2).
What the authors’ work suggests is that 
stochastic differences in effects of DNA 
replication on cancer occurrence in different 
tissues can be distinguished from effects 
of external environmental factors. This 
distinction is far from trivial. Furthermore, 
the conclusion that “[t]he concept underly-
ing the current work is that many genomic 
changes occur simply by chance during 
DNA replication rather than as a result of 
carcinogenic factors” ignores the fact that 
an initiation event must have taken place 
for a mutation to be replicated. The paper 
obscures the distinction between differences 
in cancer incidence and differences in occur-
rence of initiating events leading to cancer. 
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Cancer risk: Tumors 
excluded 
IN THEIR REPORT “Variation in cancer 
risk among tissues can be explained by the 
number of stem cell divisions” (2 January, 
p. 78), C. Tomasetti and B. Vogelstein 
discuss an interesting correlation (0.804) 
between estimated lifetime stem cell 
division number in 31 tissue types and 
corresponding cancer incidence rates in 
the United States. However, their assertion 
that only 35% of cancer risk variation is 
due to environmental or genetic factors is 
problematic. 
The correlation analysis excluded many 
cancers (such as stomach, breast, prostate, 
cervix, kidney, endometrium, bladder, 
and lymphoma) that are common in the 
United States or worldwide, so no state-
ment about overall cancer rate variation 
that is “explained” by stem cell divisions 
can be made. Furthermore, the correlation 
was anchored by five data points for osteo-
sarcoma and included tumor subtypes 
having genetic (colorectal) and environ-
mental influences (lung), but stem cell 
division rates were not estimated sepa-
rately for organ subtypes. There are strong 
time trends in cancer incidence rates and 
large incidence-rate variations interna-
tionally for nearly all cancer types [for 
example, the rate of squamous esophagus 
cancer among men with the high-
est incidence (Jiashan County 
in China and African 
Americans in South 
Carolina) is more than 
100 times the rate 
among men with 
the lowest inci-
dence (Algeria) 
(1)]. If interna-
tional rates were 
added to Figure 
1, a much smaller 
fraction of inci-
dence rate variation 
would be explained 
by stem cell divisions. 
Moreover, as the authors 
note, “The total number 
of stem cells in an organ and 
their proliferation rate may of course be 
influenced by genetic and environmental 
factors,” so that stem cell division numbers 
could serve, substantially, as a mediator 
of genetic and environmental influences, 
rather than a distinct etiologic factor. 
Finally, high values of the authors’ extra 
risk score (ERS) are described as arising 
when “there is high cancer risk relative 
to the number of stem cell divisions,” but 
ERS is calculated not as the ratio, but as 
the product, of cancer incidence rates 
and stem cell division number. Hence 
the resulting classification into D and R 
tumors does not seem interpretable and, 
regardless, could aim only to identify 
tumors that have etiologic mechanisms 
other than stem cell division number. 
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Cancer risk: Role of 
chance overstated 
THE RECENT ASSERTION from C. Tomasetti 
and B. Vogelstein that most variation in 
cancer risk among tissues is due to “bad 
luck” demands close consideration, espe-
cially as they go on to argue for increased 
focus on early detection (“Variation in can-
cer risk among tissues can be explained by 
the number of stem cell divisions,” Reports, 
2 January, p. 78). Observations from cancer 
epidemiology and limitations in their 
analysis argue strongly against this con-
clusion. Most cancers show considerable 
differences in incidence rates between dis-
tinct populations. Rates change over time, 
and migrants soon exhibit incidence rates 
similar to their host country. Each of these 
is consistent with a major etiologic role for 
environment and lifestyle. Consequently, a 
majority of cancers are preventable, with 
primary prevention achieving notable suc-
cesses and promising more (1). 
In their analysis, the authors correlate 
total stem cell divisions in selected organs 
or sites, and lifetime risk of a particular 
cancer at those sites. There is much uncer-
tainty in the estimates of total stem cell 
divisions for each cancer site, and the vast 
age-related fluctuations in cell division for 
some tissues are overlooked. Of 
greater concern is the life-
time risk of cancers. Their 
analysis excludes fre-
quent cancers with 
major environmen-
tal causes (such as 
stomach, breast, 
and cervix) and 
oversamples 
cancers rare in 
all populations 
(such as osteo-
sarcomas, small 
intestine, and 
medulloblastoma). 
Overall, the cancer 
sites included account 
for only 34% of the cancer 
cases in the United States (2). 
The choice of the U.S. population is also 
arbitrary. A different population with 
different cancer patterns would have pro-
vided different results. 
We also take issue with the statistical 
analysis. Despite the reported correla-
tion of 0.81, stem cell replication is a poor 
predictor of incidence rates at any given 
cancer site. The residual standard devia-
tion of the log rates is 0.75, so the 95% 
confidence limits for the log rate of any 
cancer site are given by the linear predic-
tor ±1.47 (i.e., 1.96 × 0.75). Converting from 
a log10 scale to an absolute scale gives an 
error factor of 101.47=29.4; i.e., the incidence 
rate may be 30 times higher or 30 times 
lower than the value predicted by stem cell 
division rates alone. This residual variation 
is consistent with large effects of environ-
mental and lifestyle factors. 
The role of chance underlying the onset 
of any individual cancer has long been 
recognized (3). However, although impor-
tant for the individual, chance has little to 
say about the incidence rate in a popula-
tion, or differences between populations. 
These are far better explained by exposure 
to environmental and lifestyle factors, 
allowing important opportunities for, and 
supporting implementation of, primary 
prevention.
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Cancer risk: 
Prevention 
is crucial 
AS CANCER 
prevention sci-
entists, we read 
C. Tomasetti and 
B. Vogelstein’s 
Report “Variation 
in cancer risk 
among tissues can 
be explained by the 
number of stem cell 
divisions” (2 January, 
p. 78) with considerable 
interest. Many of the findings 
support previous research: Cancers vary in 
preventability, and the cancers that cause 
the most mortality in developed countries 
(lung and colon) are highly preventable 
(1). However, other findings in the Report 
do not reflect the current evidence. 
For example, many of the “R-tumor” 
type cancers that the authors hypothesize 
to be unlikely to be preventable have 
well-known modifiable risk factors, such 
as tobacco and alcohol use for esophageal 
and head and neck cancers, radon expo-
sure for lung cancer in nonsmokers, and 
ultraviolet light exposure for melanoma 
(1). There is also well-documented varia-
tion in cancer incidence rates for these 
and other cancers, globally and due to 
migration, as well as over time (1). These 
kinds of changes do not seem to be com-
patible with the theory that these cancers 
originate primarily from random stem cell 
mutations. 
Tomasetti and Vogelstein found 
an interesting statistical relationship 
between rates of stem cell division and 
cancer rates in selected tissues, but they 
overinterpret the results by implying 
a causal relation. Emerging evidence 
suggests that stem cell division rates, 
and errors in division, are not simply a 
product of time and chance; they vary due 
to many external influences, including 
obesity, environmental pollution, infec-
tions, and inflammation (2, 3).
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Cancer risk: Many 
factors contribute 
IN THEIR REPORT “Variation in cancer 
risk among tissues can be explained by the 
number of stem cell divisions” (2 January, 
p. 78), C. Tomasetti and B. Vogelstein found 
a high correlation between the number of 
lifetime stem cell divisions of a given tissue 
and the lifetime risk of cancer in that tis-
sue. Based on the finding that 65% of the 
variation in cancer risk among different 
tissues can be explained by the number 
of stem cell divisions in those tissues, 
the authors concluded that “these results 
suggest that only a third of the variation 
in cancer risk among tissues is attribut-
able to environmental factors or inherited 
predispositions.” This conclusion presumes 
that the total contribution of different 
components to variation in cancer risk 
among tissues adds up to 100%. However, 
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most cancers are caused by multiple 
overlapping factors, and the at tribut-
able fractions for individual factors can 
add up to more than 100%. Furthermore, 
Tomasetti and Vogelstein suggest using the 
extra risk score (ERS) to direct allocation 
of primary versus secondary prevention for 
different cancers. However, although the 
ERS indicates how important the stochas-
tic effects of DNA replication are for the 
variation in cancer rates across organs, it 
does not inform about the preventability 
of a certain cancer in the population. As 
shown in Figure 1 in the Report, a wide 
variation in cancer rates exists even within 
highly proliferative tissues, indicating a 
substantial role of non-stochastic factors 
in carcinogenesis (such as sun exposure for 
melanoma, tobacco for lung cancer, viruses 
and obesity for hepatocellular carcinoma, 
and obesity and tobacco for pancreatic 
ductal adenocarcinoma) and an enormous 
potential for primary prevention. The 
proportion of cancer cases that can be 
potentially prevented by environmental 
(mainly lifestyle) modification should be 
estimated on the basis of the comparison 
of cancer rates across populations with 
different risk factor profiles (1, 2), rather 
than the comparison of cancer rates across 
tissues within individuals.
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Cancer risk: Accuracy 
of literature
WE READ WITH INTEREST the recent 
cancer etiology Report “Variation in cancer 
risk among tissues can be explained by 
the number of stem cell divisions” (2 
January, p. 78), in which C. Tomasetti and 
B. Vogelstein claim that most cancer risk 
can be explained by chance mutations. 
However, the selection criteria used for 
cancer types included in the study are not 
robust. First, the authors report using an 
“extensive literature search” to identify 
eligible tissue types. There is no evidence 
that a systematic literature review was 
conducted. Second, the assessment of 
literature quality and subsequent inclusion 
criteria is not clear. According to the 
authors, “Other cancer types could not be 
assessed, largely because details about the 
normal stem cells maintaining the tissue 
in homeostasis have not yet been agreed 
upon or accurately quantified.” There have 
been volumes written about the necessity 
of systematic literature reviews and 
subsequent appraisal as a criti-
cal component of obtaining 
accurate and unbiased 
research results (1). 
The method used 
by Tomasetti and 
Vogelstein leads to the 
exclusion of breast 
and prostate cancer, 
together accounting 
for ~25% of all newly 
diagnosed cancers (2). No 
doubt other cancer types are 
excluded as well. Breast and 
prostate cancer have been closely 
studied, in many cases to a much greater 
extent than those cancers that the authors 
select. Lack of agreement regarding 
accurate quantification of these cell types 
should be addressed by sensitivity analysis 
rather than exclusion. Large bodies of 
literature will invariably contain disagree-
ment between authors. This is hardly 
justification for exclusion.
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Response
THESE LETTERS CONTINUE the healthy 
and intelligent debate among scientists 
and the public about the root causes of 
cancer and the best way to reduce cancer 
deaths. The debate hinges on the follow-
ing question: What causes the mutations 
that are responsible for cancer? Two 
causes—environmental and hereditary fac-
tors—have long been recognized. A third 
cause—mutations that arise during normal 
stem cell divisions in the absence of exog-
enous factors—was also known, but there 
had been no way to measure the relative 
importance of these mutations in cancers 
and compare them to the other causes. 
Our analysis enabled such a measurement, 
and we found evidence for a surprisingly 
large role of these mutations, henceforth 
called replicative mutations. 
Suppose we had discovered a muta-
genic, industrial agent that was present 
in human tissues at concentrations that 
were very highly correlated with can-
cer incidence. The implications of this 
discovery would be obvious. But such 
an imaginary discovery is highly 
analogous to the one reported 
in our paper. The difference 
is that the “agent” is not 
exogenous. Replicative 
mutations are unavoid-
able. They are in a 
sense a side-effect of 
evolution, which can-
not proceed without 
them. That they play 
a larger role in cancer 
than previously believed 
has important scientific and 
societal implications.
At least three reactions to our 
paper have emerged. To some, the idea 
that we cannot completely control our 
cancer destinies by living a perfect life-
style in a perfect environment, even when 
we have no hereditary predisposition to 
cancer, has proved unsettling. To oth-
ers, our paper had a completely different 
message. That a child has cancer is bad 
enough; that a parent may feel guilty 
for failing to avoid a certain life-style or 
environment, and thereby “causing” that 
cancer, is agonizing. We chose to use the 
word “bad luck” particularly because we 
were aware of the unjustified guilt felt by 
many patients and their families about 
cancers that were beyond their control. 
The third reaction is fear that recognition 
of a major role for “bad luck” in cancer 
could lead individuals to conclude that 
all types of cancer are unpreventable and 
there is nothing they can do to avert any 
of them. We and many others, including 
those who have written Letters to Science, 
have vigorously campaigned against this 
mistaken belief (1, 2).
Ashford et al. state that “some mutations 
are initiated by chemical or viral exposures, 
and others occur without a known cause,” 
leaving open the possibility that other 
mutations are caused by chemical or viral 
exposures that have not yet been identified. 
The views of Ashford et al. stem from influ-
ential studies carried out in 1947 in which 
mice were treated topically with a single 
dose of a strong mutagen (i.e., initiator), 
followed by repeated topical doses of croton 
oil (i.e., promoter) (3). Ashford et al. thus 
state that our study “ignores that fact that 
an initiation event must have taken place 
for a mutation to be replicated.” In contrast, 
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our view is that no exposure to an exog-
enous agent is required for tumor initiation. 
Replicative mutations can be responsible for 
either initiating the process of tumorigenesis 
or for driving tumor progression.  
Potter and Prentice and Wild 
et al. suggest that if we had 
been able to include 
other cancer types, 
particularly com-
mon cancer types 
such as those of 
the prostate and 
breast, we might 
have concluded 
that less than 
two-thirds of 
the variation in 
cancer risk across 
tissues is ascribable 
to replicative mutations. 
We stated in our Report 
that we could only include 
cancers in which normal stem cells 
had been well-characterized, and agree that 
this was a limitation of our study. However, 
Cancer Research UK estimates that no cases 
of prostate cancer and only 27% of breast 
cancers are preventable (4). Therefore, once 
adequate research on the stem cells in these 
organs is performed, we expect that the 
inclusion of these cancers will not signifi-
cantly affect the correlation coefficient we 
observed [see (5) for more details]. 
We agree with Potter and Prentice and 
Wild et al. that the evaluation of data from 
other countries in the same way will be 
valuable. However, those data will not affect 
our conclusion that “stochastic effects asso-
ciated with DNA replication contribute in a 
substantial way to human cancer incidence 
in the United States.” Although replica-
tive mutations are expected to vary little 
among populations, inherited mutations 
and environmentally based mutations are 
known to vary considerably. For example, 
in a country where everyone smokes and 
is obese, the correlation between stem cell 
divisions and cancer rates will be far lower 
than 0.80 because avoidable factors play a 
greater role. 
Potter and Prentice criticize our multi-
plication of two logarithms to derive extra 
risk score (ERS). It may seem unintuitive 
to multiply rather than add logarithms, 
but both are valid mathematical operations 
to apply, with different interpretations. A 
detailed explanation of the mathemati-
cal basis of the ERS was provided in the 
Supplementary Materials and is expanded 
upon in our Technical Report (5).
Potter and Prentice and Gotay et al. state 
that genetic and environmental influences 
could influence the total number of stem 
cell divisions. We agree, which is why we 
defined replicative mutations to exclude 
such effects. Replicative errors occur at 
rates that can be measured in totally nor-
mal cells in vitro in the absence of 
any carcinogens. Carcinogens 
and hereditary factors 
add extra mutations 
to the baseline level 
established by the 
unavoidable repli-
cative mutations.
Wild et al. state 
that “a major-
ity of cancers 
are preventable.” 
The Centers for 
Disease Control 
(CDC) estimates that 
21% of cancer deaths 
are potentially prevent-
able in the United States 
(6). The most recent estimate 
from Cancer Research UK is that 
42% of cancers in the UK are prevent-
able (4). These two organizations, as well 
as the World Health Organization Wild 
et al. represent, are committed to cancer 
prevention efforts and to identifying and 
implementing strategies to reduce cancer 
risk. Nothing in our study contradicts 
their estimates of potentially preventable 
cancers. To the contrary, our data provide a 
mechanism to help understand the molec-
ular basis for the CDC’s estimate (as noted 
above, our cancer incidence data were 
derived from a U.S. population).
Wild et al. also state that 
“although important for 
the individual, chance 
has little to say about 
the incidence rate in a 
population” and com-
ment about prediction 
of “incidence rates at any 
given cancer site.” Our 
results specifically demon-
strate that chance plays an 
important role in the incidence 
rate in a population. Our approach 
explains variation in cancer incidence 
across tissues, rather than providing pre-
diction at any particular cancer type.
Wild et al. support their claim that 
“the role of chance…has long been rec-
ognized” with a reference to the classic 
studies of Armitage and Doll (7). This 
claim illustrates that the role of replica-
tive mutations in cancer is not adequately 
appreciated, even today. Armitage and 
Doll’s work was directed to understanding 
“carcinogenesis” considering “the ages at 
which the subjects are exposed” to various 
carcinogens. There are no such exposures 
required for replicative mutations.
Song and Giovannucci state that the 
“attributable fractions for individual fac-
tors could add up to more than 100%.” 
The potential causes of mutations, and 
therefore cancer, can be partitioned in two 
subsets: factors related to the number of 
stem cell divisions and factors unrelated to 
those divisions. Thus, by assumption, these 
two causes add up to explain exactly 100% 
of the variation in risk. 
We agree with Song and Giovannucci 
that the preventability of specific cancer 
types is more precisely estimated by epi-
demiologic evaluations than by ERS. The 
ERS provides a rough idea of the potential 
preventability of individual cancer types, 
but only in relation to other cancer types 
rather than in absolute terms (5). At the 
same time, our work provides a way to 
calculate the evidence for such extra risks 
that is free from all assumptions used 
previously. The idea that two-thirds of the 
relative variation in cancer risk can be 
explained (correlation coefficient of 0.80), 
and the relative environmental or heredi-
tary influences roughly estimated, from a 
single biological feature (number of stem 
cell divisions) is unprecedented.
With respect to comments of 
O’Callaghan, our study was not intended 
to be a meta-analysis such as that used to 
evaluate clinical interventions. We used 
PubMed to find all the references we could 
and used our judgment to select 146 that 
we considered among the most reli-
able. However, we did not have 
complete trust in our judg-
ment, nor complete trust in 
the estimates made in the 
original references. We 
therefore performed rig-
orous tests for robustness 
of the conclusions based 
on these estimates. For 
example, statistical signifi-
cance persisted even when 
we allowed the reported 
estimates of stem cell divi-
sions to vary by ~100-fold in either 
direction [see our Report, Supplementary 
Materials]. Few meta-analyses would sur-
vive robustness tests like these.
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TECHNICAL COMMENT 
ABSTRACTS
Comment on “Using ecological 
thresholds to evaluate the costs and 
benefits of set-asides in a biodiversity 
hotspot”
Christopher Finney
Banks-Leite et al. (Reports, 29 August 
2014, p. 1041) conclude that a large-scale 
program to restore the Brazilian Atlantic 
Forest using payments for environmental 
services (PES) is economically feasible. 
They do not analyze transaction costs, 
which are quantified infrequently and 
incompletely in the literature. Transaction 
costs can exceed 20% of total project costs 
and should be included in future research.
Full text at http://dx.doi.org/10.1126/sci-
ence.aaa0916
Response to Comment on “Using 
ecological thresholds to evaluate the 
costs and benefits of set-asides in a 
biodiversity hotspot”
Cristina Banks-Leite, Renata Pardini, Leandro 
R. Tambosi, William D. Pearse, Adriana A. 
Bueno, Roberta T. Bruscagin, Thais H. Condez, 
Marianna Dixo, Alexandre T. Igari, Alexandre 
C. Martensen, Jean Paul Metzger
Finney claims that we did not include 
transaction costs while assessing the 
economic costs of a set-aside program in 
Brazil and that accounting for them could 
potentially render large payments for envi-
ronmental services (PES) projects unfeasible. 
We agree with the need for a better under-
standing of transaction costs but provide 
evidence that they do not alter the feasibility 
of the set-aside scheme we proposed.
Full text at http://dx.doi.org/10.1126/sci-
ence.aaa1602
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